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1. Introduction
  Hyperlipidemia is a condition, which characterized 
by elevated serum total cholesterol, triglyceride, and 
lipoproteins such as low density lipoprotein cholesterol 
(LDL-c), very low density lipoprotein cholesterol (VLDL-c) 
and decreased high density lipoprotein cholesterol 
(HDL-c)[1]. These are the biomarkers for elevated risk 
of cardiovascular diseases such as atherosclerosis, 
coronary artery diseases and cerebral vascular diseases[2]. 
Oxidative stress has been prescribed as the main 
mechanism responsible for cardiovascular diseases while 
hypercholesterolemia under oxidative stress could trigger 
the progression of atherosclerosis and abnormal lipid 
metabolism[3]. The generation of reactive oxygen species 
(ROS) including superoxide anions, hydrogen peroxide (H2O2) 
and hydroxyl radicals would react with unsaturated fatty 
acid chain in membrane lipids and cause lipid peroxidation. 
Certain primary and secondary lipid peroxidation products 
would decompose into malondialdehyde (MDA)[4]. Hence, 
elevated of malondialdehyde in serum is a biological 
marker of lipid peroxidation. The literature studies in both 
animals and humans have demonstrated that prolonged high 
Objective: To determine the antihypercholesterolemic effects of kenaf seed samples and compare 
with the commercial hypocholesterolemic drug on serum lipids profiles and malondialdehyde 
(MDA) level in the rat. Methods: Kenaf seed oil (KSO), microencapsulated kenaf seed oil (MKSO), 
kenaf seed extract (KSE) and defatted kenaf seed meal (DKSM) were prepared and phytochemicals 
screening on these samples were done prior in vivo study. Phenolic compounds in KSE were 
quantified using high performance liquid chromatography. There were 40 (divided in eight diet 
groups of 5) male Sprague dawley rats adapted to normal standard diet or hypercholesterolemic 
diet (HD) with or without the treatment of these kenaf samples for 32 days. Results: All the kenaf 
samples exhibited to contain most of the major phytochemicals. KSE possessed gallic acid, tannic 
acid, catechin, benzaldehyde, benzoic acid, syringic acid, sinapic acid, ferulic acid, naringin 
acid, and protocatechuic acid. The significant higher (P<0.05) serum total cholesterol, low density 
lipoprotein cholesterol and MDA levels in HD group without treatment than the normal control 
group suggested the hypercholesterolemia was induced by the incorporation of cholesterol into 
diet. KSE exhibited higher cholesterol-lowering properties due to the significant lower (P<0.05) 
in serum triglycerides, total cholesterol and MDA levels. KSE showed the highest efficiency of 
cholesterol-lowering activity, followed by KSO, MKSO and DKSM. Conclusions: DKSM, MKSO, 
KSO and KSE appeared to have comparable anti-hypercholesterolemic effect with the commercial 
hypocholesterolemic drug. Hence, kenaf seed could be used as an alternative natural source to 
replace the synthetic hypocholesterolemic drugs.
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cholesterol concentration in the circulating blood positively 
correlates with developing atherosclerosis[5,6].
  Kenaf (Hibiscus cannabinus L.) has been well-known 
especially to its seed which was disposed as industrial 
waste or by-product in the past. The relatively high oil 
level and the reasonable amounts of phytosterols and 
phospholipids suggest that kenaf oil can be used as a source 
of edible oil[7]. Kenaf seed oil has a relatively high amount of 
monounsaturated and polyunsaturated fatty acids (PUFAs), 
which are nutritionally beneficial for human health[8]. The 
PUFAs and phytosterols content in kenaf seed oil have 
cholesterol lowering ability, which are beneficial to human 
health[9]. In the most recent study, microencapsulation 
has been applied to overcome the problem associated 
with lipid oxidation in the kenaf seed oil due to the high 
PUFA levels, which are susceptible to oxidation. The 
microencapsulated kenaf seed oil (MKSO) was reported to 
possess abundant of bioactive compounds and unsaturated 
fatty acids even after spray drying process[10]. Recently, 
numerous attempts to replace solvent extraction have been 
made, of which ultrasonic-assisted extraction (UAE) is one 
of the most promising methods[11-13]. This could be related 
to its improvements in efficiency and speed, which can be 
performed at low operation temperatures. Hence, thermal 
damage to the extracts and preserves the structural and 
molecular properties of bioactive compounds could be 
minimized and avoided[11,14,15]. Therefore, the UAE was used 
to obtain the kenaf seed extract. The mass extraction of kenaf 
seed oil resulted in large amounts of defatted kenaf seed 
meal (DKSM) as kenaf seed contains only approximately 20% 
of oil[16]. In fact, DKSM may be declared and commercialized 
as highly antioxidative and nutritive edible flour, which can 
be prospectively used in the development of natural food 
preservative, nutraceuticals and functional foods.
  To the best of our knowledge, the consequence of the 
consumption of diets containing these kenaf seed oil, 
defatted seed meal and extracts on circulating lipid has 
not been examined. The current study was conducted to 
determine the effect of kenaf seed on high-fat diet Sprague 
dawley rats in altering the serum lipid profile and MDA 
level. The study hypothesis was that the unsaturated fatty 
acids and bioactive compounds in kenaf seed would have 
anti-hypercholesterolemic effect and also able to reduce 
oxidative stress on the studied rats. To test this hypothesis, 
hypercholesterolemic diet (HD) was introduced to the 
studied rats. The rats were divided into several groups and 
treated with different kenaf seed samples, respectively. The 
effects of consumption of these samples were compared 
among each others as well as compared with the commercial 
hypocholesterolemic drug on serum lipids profiles and MDA 
level in the rats. Therefore, new alternative natural plant 
source can be produced to be the replacement for synthetic 
hypocholesterolemic drugs.
2. Materials and methods
2.1. Samples
  Kenaf (Hibiscus cannabinus L.) seeds were obtained 
from Malaysian Agricultural Research and Development 
Institute. Wall materials, such as sodium caseinate (China), 
maltodextrin DE10 (China) and soy lecithin (China; used as 
an emulsifier) were purchased from a local food ingredient 
supplier (VIS Food Tech Ingredient Supplies, Malaysia). All 
chemicals used were analytical grade (Merck, Darmstadt, 
Germany).
2.1.1. Kenaf seed oil (KSO)
  Extraction of oil was done according to the method of 
previous study[10]. The kenaf seeds were ground into fine 
powder using a grinder (National, Osaka, Japan). The oils 
were extracted from the seeds with Soxhlet extractor using 
hexane at 60 曟 for 8 h. The oil was then recovered by 
evaporating off the solvent using rotary evaporator Model 
N-1 (Eyela, Tokyo Rikakikal Co., Ltd., Japan) and residual 
solvent was removed by flushing with 99.9% nitrogen.
2.1.2. DKSM
  The defatted seeds were obtained after the oil extraction, 
which were subsequently placed under a stream of hot air in 
a ventilated oven (Memmert, Germany) at 50 曟 to remove the 
residual solvent. 
2.1.3. Kenaf seed extract (KSE)
  A total of 50 g of ground kenaf seed was added to a 
500 mL Schott bottle containing 500 mL of 80% ethanol. 
Ultrasonic extraction (Ultrasonic Homogenizer Labsonic 
P, 400 W, Sartorius, AG) was done for 30 min with a 5-min 
pulse duration period and a 5-min pulse interval period. 
The extraction was repeated for 3 cycles. The kenaf seed 
extract collected was centrifuged at 3 500 rpm for 10 min. 
The supernatant of the kenaf seed extract was collected and 
filtered; the pellet was discarded.  The filtered supernatant 
was subjected to rotary evaporation.
2.1.4. Microencapsulated kenaf seed oil (MKSO)
  Microencapsulated of kenaf seed oil was prepared 
according to previously described method[10]. Briefly, 
kenaf seed oil (core) was added to pre-dissolved wall 
materials (sodium caseinate/maltodextrin ratio of 1:9) 
at the ratio of 1:3 to obtain a 40% of total solids level of 
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emulsion. Subsequently, 2 g of soy lecithin was added as 
an emulsifier (emulsifier/protein ratio of 0.1:1). The mixture 
was then homogenised in a shear homogeniser (Silverson 
L4R, Buckinghamshire, UK) for five min at 3 000 rpm until 
complete dispersion was observed. The resultant emulsions 
were further homogenised in a high-pressure homogeniser 
(APV, Crawley, UK) at pressure of 500 bars for four cycles. 
For spray drying, the emulsion was spray-dried in a Buchi 
B-290 model mini spray dryer (Buchi Labortechnik AG, 
Switzerland) equipped with a 0.7 mm standard diameter 
nozzle at the inlet temperature of 160 曟 and outlet 
temperature of (85依2)曟. 
2.2. Phytochemical screening
  Prior to analyses, the total oil of MKSO was extracted 
out from the wall material[10]. In the preparation of de-
emulsifier, 10 g of sodium salicylate and 10 g of sodium 
citrate were dissolved separately in deionised water, 
followed by mixing these solutions together with 18 mL of 
n-butanol, and top up to 90 mL with deionised water. Every 
10 g of MKSO was mixed with 20 mL water at 50 曟 in an 
Erlenmeyer flask with a stopper. 15 mL of the pre-prepared 
de-emulsifier was added in, and the mixture was shaken 
vigorously and left to stand in a 70 曟 water bath for 6 min. 
The resulting mixture was then centrifuged (Centrifuge 
machine X-22R, Beckman Coulter, United State) at 3 000伊
g for 10 min, and the total oil (supernatant) was collected. 
The KSE, KSO and DKSM and total oil extracted from MKSO 
were evaluated for the presence of different phytochemicals 
to ascertain the presence of metabolites such as terpenoids, 
tannis, cardiac glycosides, alkaloids, saponins, and 
flavonoids by using the procedures described by Ayoola et 
al[17], Parekh et al[18] and Usman et al[19].
2.3. Phenolic compounds quantification
  Phenolic compounds in KSE were quantified using high 
performance liquid chromatography (HPLC) as previously 
described method[20] with slightly modification. The HPLC 
(Agilent Technologies 1200 Series, United Stated) system 
consisted of diode array detector. Separation of phenolic 
compounds was carried out using a reversed-phase HPLC 
column (Purospher star 5 毺m伊250 mm伊4.6 mm). The 
column temperature and detection wavelength were set at 
30曟 and 210 nm, respectively. A gradient elution system 
of solvent A (Water with 0.1% phosphoric acid) and solvent 
B (methanol with 0.1% phosphoric acid) was used [5% B 
(0 min); 50% B (5 min); 55% B (65 min); 5% B (70 min)]. The 
flow rate was 1 mL/ min. The volume injected was 20 毺L. 
The chromatographic peaks of phenolic compounds were 
confirmed by comparing their retention times with those of 
the reference standards. Gallic acid, tannic acid, catechin 
hydrate, 4-hydroxybenzaldehyde, 4-hydroxybenzoic acid, 
syringic acid, sinapsic acid, ferullic acid, naringin, and 
protocatechuic acid were used as phenolic compound 
standards.
2.4. Experimental animals
  Male Sprague dawley rats (250-300 g) that used for this 
study were obtained from the institutional animal house 
(Universiti Kebangsaan Malaysia, Bangi, Malaysia). The 
animals were housed two or three in each cage under 
standard laboratory conditions (temperature at (22依2)曟,
and humidity at (75依5)% with a 12 h dark-light cycle. The 
animals were fed with meat free rat and mouse diet (as 
normal standard diet) that purchased from Speciality Feeds 
(Glen Forrest, Western Australia) and were allowed to drink 
water ad libitum. The animals were allowed to acclimatize 
for 2 weeks before the treatments started. The research on 
animal models was approved by the Faculty’s adhoc ethics 
committee of UCSI University (Cheras, Malaysia) with project 
code Proj-FAS-EC-12-019. The experimental procedures 
were in strict accordance with animal ethical committee 
guidelines for the care and use of laboratory animals.
2.5. Diet preparation
  HD was used to induce the hyperlipidemia among the 
experimental animals. The composition of HD was 10% 
cholesterol (Sigma-Aldrich, Germany) and 90% normal 
diet. In the preparation of 100 g of HD, briefly, every 90 g of 
normal standard diet were ground into powder using grinder 
(Sharp, United State) and was mixed with 10 g of cholesterol. 
Adequate amount of distilled water was added into the 
mixture and was regimented by hand. Similar pellet-shape 
with the normal standard diet was shaped by the hand. The 
resulting pellets were dried overnight in a conventional 
oven (Memmert, Germany) at 50 曟 until a constant weight 
was obtained. Similar procedures were repeated in the 
preparation of diet for Group IV, which consisted of 10% of 
DKSM with of 90% HD. Group VII, which consisted of 10% 
MKSO. Group 桒, which consisted of 10% wall materials, 
MDSC (maltodextrin/sodium caseinate ratio of 9:1) was 
acted as negative control group to eliminate the hyper/
hypolipidemic effect that caused by the wall materials in 
Group 桏. 
2.6. Experimental protocol
  The rats were divided into 8 groups of 5 rats in each 
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group such that the weight difference within and between 
groups does not exceed依20% of the average body weight 
of the sample population. Treatments of all groups were 
shown in Table 1. The rats were fed with HD for 32 days to 
induce hyperlipidemia among the animals except normal 
control group (Group I), which fed with normal standard 
diet. A standard amount of 20 g/ rat/ day was fixed to all 
groups to eliminate the effect of unequal diets among the 
groups. Simvastatin (Teva Simvastatin®, Teva UK Limited, 
Eastbourne, UK), as positive control, KSE and KSO were 
administered by oral gavage. Body weights of rats were taken 
with Mettler weighing balance (Mettler Toledo Type BD6000, 
Mettler-Toledo GmbH, Greifensee, Switzerland) and were 
recorded weekly. All treatment was done as a single daily 
oral treatment for 32 days.
Table 1
Experimental treatments of the respective groups.
Group Diet/ treatment po. (per oral)
栺Normal control 100% Normal diet
栻Hypercholesterolemia control 100% HD
栿 Positive control 100% HD + simvastatin (40 mg/kg/d)
桇 DKSM diet 90% HD + 10% DKSM 
桋 KSE diet 100% HD + KSE (400 mg/kg/d)
桍 KSO diet 90% HD + 10% KSO
桏MKSO diet 90% HD + 10% MKSO
桒MDSC diet 90% HD + 10% MDSC
2.6.1. Measurement of body weight changes and relative liver 
weight
  The measurement of body weight changes (∆wt) and relative 
liver weight were done according to the previous described 
method[21]. The ∆wt of rats in each group were calculated 
and were expressed in percentage (%) as shown in Equation 
(1):
(body weight on day 33-body weight on day 1)/(body weight 
on day 1)伊100    (1)
  The absolute liver weight of each rat group was measured 
using Mettler weighing balance, from which the relative liver 
weight per 100 g body weight of rat was calculated according 
to Equation (2):
[Weight of rat liver (g)/body weight on day 33 (g)]伊100  (2)
2.6.2. Collection of serum 
  At the end of treatment period, the animals were fasted for 
18 h to 24 h after the last administration. The animals were 
then anaesthetized with Ketamine (Sigma-Aldrich, Germany) 
at dosage of 500 mg/ kg with intraperitoneal method. Blood 
samples were collected from posterior vena cava and were 
transferred into ethylenediaminetetraacetic acid tubes 
immediately to prevent coagulation of bloods. The collected 
blood samples were centrifuged using centrifuge machine 
(X-22R, Beckman Coulter, United State) at 3 000伊g for
15 min at 4 曟 to remove red blood cells and recover 
serum[22]. The serum samples (supernatant) were collected 
and were used for the following analyses.
2.6.3. Analysis of serum lipid profile
  The serum lipid profile was determined including total 
cholesterol (TC), triglycerides (TG), HDL-c and LDL-c were 
analysed using Cobas C 311 analyzer (Roche, Germany)[23].
2.6.4. Determination of AI and CRI
  Atherogenic index (AI) and coronary risk index (CRI) were 
calculated according to the prescribed method[21] as shown 
in Equation (3) and (4), respectively:
LDL-c (mmol/L)/ HDL-c (mmol/L)               (3)
TC (mmol/L)/ HDL-c (mmol/L)                      (4)                            
2.6.5. Determination of serum MDA level 
  Serum MDA was measured by the thiobarbituric acid 
reactive substances (TBARS) assay[22]. Briefly, 20% 
trichloroacetic acid (1.0 mL) was added to 100 毺L serum, 
then 1% TBARS reagent (1.0 mL) was added, mixed and 
incubated at 100 曟 for 30 min. After cooling on ice, samples 
were centrifuged using centrifuge machine at 1 000伊g for
20 min and absorbance of the supernatant was read at 532 
nm by UV-Vis spectrophotometer (Secoman, France). Blanks 
for each sample were prepared and assessed in the same way 
to correct for the contribution of A532 to the sample. TBARS 
results were expressed as micromole MDA production 
per liter (毺mol/L) serum, using tetramethoxypropane as 
standard. 
2.7. Statistical analysis
  All the results were analysed using Minitab software 
(Version 15.1.1.0) and SPSS software (Version 10.0). Data 
were expressed as mean依standard deviation (n=5). One-
way analysis of variance (ANOVA) was used to determine 
significant difference (P<0.05) between the means.
3. Results
3.1. Phytochemicals screening
  Table 2 shows that the presences of phytochemicals in 
KSO, DKSM, KSE and MKSO. Terpenoids, tannis, cardiac 
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glycosides, alkaloids, saponins and flavonoids were present 
in all samples. Cardiac glycosides was absent in DKSM and 
KSE, respectively. 
Table 2
Phytochemicals in KSO, DKSM, KSE and MKSO.
Phytochemical KSO DKSM KSE MKSO
Terpenoids + + + +
Tannis + + + +
Cardiac glycosides + - - +
Alkaloids + + + +
Saponins + + + +
Flavonoids + + + +
Present (+); Absent (-).
3.2. Phenolic compounds
  Phenolic compounds in KSE (Table 3), revealing the 
presence of gallic acid, tannic acid, catechin, benzaldehyde, 
benzoic acid, syringic acid, sinapic acid, ferulic acid, 
naringin acid, and protocatechuic acid. Tannic acid (2302.20 
mg/100g extract) and sinapic acid (1 198.22 mg/100g extract) 
were the major compounds in KSE. 
Table 3
Quantitative of phenolic acid content in ultrasound-assisted KSE.
Phenolic acid Kenaf seed extract (mg/100 g)
Gallic acid   123.36依0.31
Tannic acid 2 302.20依16.48
Catechin hydrate   502.73依1.98
4-hydroxybenzaldehyde   116.14依7.87
4-hydroxybenzoic acid   255.84依7.74
Syringic acid     61.56依5.97
Sinapsic acid 1 198.22依121.82
Ferullic acid   288.38依14.05
Naringin     43.79依13.19
Protocatechuic acid   170.83依8.22
Total 5 880.56依685.24
3.3. Body weight changes (% ∆wt) and relative liver weight
  The body weight changes and relative liver weight of the 
studied rats after 32 days were shown in Table 4. HD caused 
increased of body weight in the studied rats, which could 
be seen from the relatively higher weight gained among all 
the rats fed with HD either with or without treatment (Group 
栻- Group 桒). However, no significant difference (P>0.05) 
in weight gained among all the HD fed rat groups with 
the normal standard diet control rats was observed except 
Group 栿. Treatment of 40 mg/ kg/ day of simvastatin caused 
significant weight gained in the studied  rats, which was 
significantly higher (P<0.05) than the normal standard diet 
control rats. The rats fed with HD without treatment revealed 
the significant higher (P<0.05) relative liver weight than the 
control rats and rats fed with KSO treatment rats.
Table 4
Effect of different treatments on the percentage body weight changes 
(% ∆wt) and relative liver weight in the studied rats.
Group % ∆wt Relative liver weight
栺 12.65依2.13
b 2.66依0.21bc
栻 23.80依3.06
ab 3.61依0.68a
栿 26.89依5.05
a 2.96依0.21abc
桇 16.32依2.83
ab 2.85依0.10abc
桋 15.28依6.66
ab 2.83依0.31abc
桍 18.10依10.05
ab 3.33依0.47ab
桏 20.07依3.59
ab 2.41依0.18c
桒 20.60依1.12
ab 2.92依0.25abc
Data are mean依standard deviation (n=5) with different superscript 
letters abc within the same column indicate significant differences 
(P<0.05).
3.4. Serum lipid profile
  Table 5 shows the serum lipid profile of all studied rats. 
HD feeding without treatment rats revealed the significant 
highest (P<0.05) amount of serum TC levels and LDL-c. All 
the rats fed with HD and treated with the different kenaf 
samples (Group 栿- 桏) were shown to have significant 
lower (P<0.05) amount of TC levels than the untreated rats 
(Group 栻). No significant difference (P>0.05) of HDL-c was 
observed among all the studied rats. The TC and LDL-c of 
the rats treated with MKSO were shown to be lower than the 
Group 桒 (negative control group), which the rats that were 
fed with wall materials (MDSC). 
3.5. Atherogenic index (AI) and coronary risk index (CRI) 
  Rats treated with simvastatin, KSE and MKSO showed to 
Table 5
Effect of different treatments on serum TC, TG, HDL-c, LDL-c, CRI, AI, and MDA levels in the studied rats.
Group TC(mmol/L) TG(mmol/L) HDL-c(mmol/L) LDL-c(mmol/L) AI CRI MDA(毺mol/L)
栺 1.43依0.13
c 0.57依0.17a 1.08依0.08abc 0.12依0.08c 0.11依0.08c 1.33依0.18c 0.10依0.01b
栻 2.29依0.25
a 0.69依0.17a 1.08依0.15abc 0.88依0.26a 0.84依0.31a 2.16依0.40a 0.14依0.01a
栿 1.53依0.14
bc 0.70依0.09a 0.85依0.08c 0.35依0.13bc 0.41依0.14bc 1.79依0.13abc 0.06依0.01c
桇 1.86依0.25
b 0.73依0.36a 1.08依0.14abc 0.45依0.10b 0.42依0.08ab 1.73依0.18abc 0.08依0.01bc
桋 1.59依0.09
bc 0.64依0.45a 1.12依0.14abc 0.18依0.13bc 0.15依0.11c 1.42依0.13bc 0.06依0.01c
桍 1.59依0.08
bc 0.51依0.09a 0.87依0.21bc 0.48依0.15b 0.61依0.34ab 1.91依0.45ab 0.08依0.01bc
桏 1.85依0.11
b 0.86依0.43a 1.20依0.18ab 0.28依0.15bc 0.23依0.13bc 1.56依0.15bc 0.08依0.01bc
桒 1.92依0.20
ab 0.53依0.14a 1.32依0.12a 0.35依0.13bc 0.26依0.08bc 1.45依0.05bc 0.10依0.02b
Data are mean依standard deviation (n=5) with different superscript letters abc within the same column indicate significant differences (P<0.05).
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have significant lower (P<0.05) of AI than the untreated 
rats. Normal diet rats exhibited the lowest AI, which was 
significantly lower than the untreated HD rats, rats treated 
with DKSM and KSO but insignificant different (P>0.05) with 
the rest of groups. Rats treated with KSE and MKSO showed 
to have significant lower (P<0.05) of CRI than the untreated 
HD rats. Similar to AI, normal diet rats revealed the lowest 
CRI, but was significantly lower (P<0.05) than the untreated 
HD rats and rats treated with KSO only (Table 5).
3.6. Serum MDA level
  MDA level has always been used as a biological marker of 
lipid peroxidation. The serum MDA level of the untreated 
HD rats was significantly higher (P<0.05) than all other 
groups. Significant lower (P<0.05) of serum MDA level of rats 
treated with simvastatin and KSE than the normal diet rats 
was observed (Table 5).
4. Discussion
  Phytochemicals are biologically active plant chemicals 
other than traditional nutrients that have a beneficial effect 
on human health[24]. The presences of phytochemicals 
including glycosides, flavonoids and terpenoids in the kenaf 
seed could possess serum lipid lowering properties that help 
in preventing or slowing the progress of atheroma related 
diseases[25]. Therefore, phytochemical screening was done 
prior to in vivo study mainly due to their antioxidant activity 
and other potential health benefits.
  Cholesterol feeding has often been used to elevate 
serum cholesterol levels to study the etiology of 
hypercholesterolemia-related metabolic disturbances[26]. 
Feeding of HD to the studied animals caused significant 
increase of serum TC and LDL-c compared to control rats. 
This is associated with the excessive load of cholesterol 
to the liver, which exceed the normal physiological limits, 
causes the inability of liver to metabolize the lipids, thus 
resulting in high cholesterol return in the circulating 
blood[27]. Consequently, the accumulation of fatty acid in 
the hepatocyte caused an increased of the relative liver 
weight[28]. This can be seen from the significant higher 
relative liver weight on the HD induced groups (both 
untreated and treated) compared to the control group. 
Similarly, the body weights gained in the HD groups were 
shown to be higher than the control diet group. HD fed to the 
studied rats induced greater body fat deposition because of 
increased in adipocyte number and size[29]. The HD groups, 
which treated with kenaf seed samples, were shown to have 
relatively lower relative liver weight and lower body weight 
gained. These indicated that the kenaf seed samples were 
able to inhibit the accumulation of fats in the body and liver.
  Linoleic acid plays an important role in reduction of total 
cholesterol level[30]. In addition, the bioactive compounds 
such that phytosterols and tocopherols play their role in 
lowering serum cholesterol level. Phytosterols (毬-sitosterol) 
and saponins could increase cholesterol excretion from 
the body. Besides, phytosterols also help in inhibition of 
cholesterol absorption[31], lower the TG and increase HDL[32]. 
The ability of vitamin E (毩-tocopherol) was reported to 
be able to reduce the serum MDA level[33] and the risk 
of cardiovascular diseases[34]. From the previous study 
done on the effect of microencapsulation on KSO, linoliec 
acid (C18:2n6c) that presence in the KSO and MKSO was 
reported as (33.6依0.2)% and (25.7依0.2)%, respectively. The 
phytosterols content in KSO and MKSO were (6 510.3依54.2) 
mg/100 g and (4 680.4依171.9) mg/100 g, respectively. Total 
tocopherols of KSO and MKSO were (186.83依2.70) mg/100 
g and (154.89依3.15) mg/100 g, repectively. Therefore, the 
anti-hypercholesterolemic properties of KSO and MKSO 
could be explained due to the presence of these bioactive 
compounds. DKSM was reported to exhibit high reducing 
power and effective radicals scavenging activity, which 
revealed that DKSM could potentially break the free radicals 
chain reactions that initiate and propagate the process of 
lipid peroxidation in food products[16]. Therefore, the free 
radicals such as ROS produced from lipid metabolism had 
been scavenged and reduce the lipid peroxidation, thus, 
lowers the serum MDA level.
  The highest level of serum MDA level and TC in the 
HD rats without treatment suggested that the lipid 
peroxidation caused hypercholesterolemia[3]. This also 
can be observed from the low serum MDA level and low 
TC in the normal diet control rats. Despite the absence of 
cardiac glycosides, KSE showed to be the most effective 
among other samples in reducing the cardiovascular risk. 
In fact, cardiac glycosides are steroidal glycosides, which 
exert a slowing and strengthen effect on the failing heart. 
They act by affecting the availability of intracellular Ca2+ 
for myocardial contraction or increasing the sensitivity of 
myocardial contractile proteins[35]. Hence, they increase 
the force of heart contraction. Treatment of HD fed rats with 
KSE effectively reduced the serum MDA level, which was 
significant difference (P>0.05) with the treatment of HD fed 
rats with simvastatin. KSE showed its ability to reduce TC 
and LDL-c in the HD fed rats. This can be explained by the 
lower levels of serum TC, LDL-c and MDA but high level 
of HDL-c in the KSE diet-treated rats. Generally, LDL-c 
is often known as “bad cholesterol” as opposed to HDL-c, 
which is known as “good cholesterol”. Elevated level 
of LDL-c promotes health problems and cardiovascular 
disease[36] while HDL-c involves in the removal cholesterol 
from within the artery and transports it back to the liver for 
excretion or re-utilization[31]. 
  UAE involves the solid-liquid extraction by ultrasound, 
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which improved the penetration of the solvent into the 
plant tissue and capillary that intensify the release of 
organic compounds such as polyphenols within the plant 
body at enhanced mass transfer rate and produced higher 
yields[37,38]. These characteristics make this extraction 
alternative very useful for isolating natural compounds from 
plants with pharmacological properties[39]. The significant 
high amount of total phenolic compounds [(5 880.56依685.24) 
mg/100 g of extract] detected in the KSE compared to DKSM 
(199.98 mg/100 g of DKSM)[16], KSO (12.23 mg/100 g of oil) 
and MKSO possessed (11.07 mg/100 g of oil)[10] suggested 
the phenolic compounds play more significant role in 
reducing oxidative stress. Tannic acid has been shown to 
possess antioxidant, antimutagenic and anticarcinogenic 
properties[40] while sinapic acid has already been 
pharmacologically evaluated for its potent antioxidant, 
anxiolytic, anti-inflammatory, peroxynitrite scavenging 
effects and neuroprotective effects[41]. In fact, these two 
major phenolic compounds in KSE were not detected in 
the KSO and MKSO[10]. Higher content of antioxidants were 
found in KSE to reduce the lipid peroxidation, which would 
prevent the occurrence of hypercholesterolemia. This study 
has demonstrated the close relationship between lipid 
peroxidation and hypercholesterolemia. In the literature, the 
investigation in vivo concluded that the sample with higher 
antioxidant capacity is biologically more active than sample 
with lower antioxidant capacity[42]. The higher antioxidant 
capacity in the KSE significantly reduced the lipid 
peroxidation, hence, reduced the serum TC and TG levels. 
  The effects of different samples treatment on the AI and CRI 
were also notable. These two indices are known as reliable 
indicators of the deposition of the cholesterols into tissues 
are being metabolized or excreted[43]. In humans, the normal 
reference values for atherogenic index should not be higher 
than 4 while the coronary artery index should not be higher 
than 2.5[44]. Thus, patients with both indices higher than 
these reference values are more prone to develop ischaemic 
heart disease and thrombotic cardiovascular disease[45]. 
In this present study, results showed that treatment with 
KSE caused the significant lower of both indices than the 
untreated HD rats, which suggested that KSE possessed 
cardioprotective potential.
  In conclusion, this study suggested that the cholesterol-
lowering activi ty of  KSE, DKSM, KSO and MKSO 
appeared to have comparable effect with the commercial 
hypocholesterolemic drug, simvastatin. Experimented diets 
did not affect the TG levels of serum. The absence of cardiac 
glycosides in KSE did not influence its effectiveness in 
lowering serum TG and LDL-c levels. Moreover, KSE had 
the significant effect in preventing lipid peroxidation in 
the rats, which was similar to simvastatin. The efficiency 
of different kenaf samples in anti-hypercholesterolemia 
were in the ascending order of DKSM < MKSO < KSO < KSE. 
Hence, this study suggested the kenaf seed samples to be 
used as an alternative natural source to replace the synthetic 
hypocholesterolemic drugs. 
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